Drugmakers to cooperate in safety review of diabetes drugs

By Bill Berkrot NEW YORK (Reuters) – Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between widely used diabetes medicines and pancreatic cancer and other safety problems. The American Diabetes Association (ADA) this week called for a new evaluation of clinical data on drugs used to control blood sugar for patients with type 2 diabetes. They include Merck & Co’s $4 billion a year Januvia franchise, Novo Nordisk’s Victoza, and Byetta and Onglyza from Bristol-Myers Squibb Co and AstraZeneca Plc, among others. …

Pennsylvania girl gets lung transplant after judge’s order

(Reuters) – A 10-year-old Pennsylvania girl with cystic fibrosis, who only became eligible for an adult organ transplant because of a judge’s order, on Wednesday received a double-lung transplant from an adult donor, her family said. Sarah Murnaghan, who had been kept off an adult organ transplant list due to an age restriction prior to the judge’s ruling, was undergoing transplant surgery at Children’s Hospital of Philadelphia, said family spokeswoman Tracy Simon. The girl’s family, which lives in the Philadelphia suburb of Newtown Square, sued to prevent the U.S. …

At-home weight loss programs for kids lack evidence

Fernanda Garcia-Villanueva, 8, takes her pulse at a group exercise session in the 10-week Shapedown Program at The Children's Hospital in AuroraBy Kathryn Doyle NEW YORK (Reuters Health) – Programs designed to prevent childhood obesity in the home don't affect kids' weight a year or more down the line, according to a review of the evidence. But that conclusion comes from only a small number of available studies on the programs, and doesn't prove that such studies can't work, according to lead author Dr. Nakiya Showell. …

1 59 60 61 62 63 101